News & media
CLL Advocates NZ Launches a New Zealand Patient Guide
CLL Advocates is pleased to announce the official launch of it's Guide for Patients in New Zealand.…
Dr. Davids on Factors to Inform Treatment Selection in CLL
Matthew S. Davids, MD, MMSc, discusses factors to consider when selecting treatment for patients…
The Role of Chemoimmunotherapy Dwindles Among New Regimens in Frontline CLL
Although frontline chemoimmunotherapy regimens have been the gold standard for patients with…
CLL Advocates NZ Newsletter Issue 4
Welcome to issue 3 of the CLL Advocates newsletter. This month's newsletter focuses on research and…
Triple Therapy for CLL Shows Promise in Phase 2 Trial
Results from a phase 2 study of 3 oral targeted agents for chronic lymphocytic leukemia (CLL)…
The CLLANZ Inaugural CLL Seminar
Three top haematologists will present and take questions on CLL disease, diagnosis and management,…
Uncommon Mutation in CLL Associated With More Favorable Prognostic Factors
Patients with CLL/small lymphocytic lymphoma (CLL/SLL) who had an MYD88 L265P mutation were…
Targeted Molecular Therapies for the Treatment of Chronic Lymphocytic Leukemia
CLL proliferate in secondary lymphatic organs where cancer cells engage in molecular and cellular…
Which Drug Therapy for CLL, Time-Limited or Continuous?
About two thirds of patients who are diagnosed with chronic lymphocytic leukemia (CLL) are…
EU approves Imbruvica plus rituximab in first-line CLL
There’s a growing recognition that some of the CAR-T shortfalls in CLL are due to an impaired…
4 October – CLL Treatments Today: What Should I Know?
Join us for a virtual town meeting for chronic lymphocytic leukemia (CLL) patients and family…
Clinical Trials Survey 2020
Please help Andrew give a powerful speech based on your experiences and thoughts around clinical…
Acalabrutinib Shows Promising Results for the Treatment of CLL
Jennifer Woyach, MD, discusses the rationale and efficacy for the phase 1/2 trial of acalabrutinib…
Online webinar: Telling Others About My CLL Diagnosis
How do you tell family and friends that you have leukemia? Chronic Lymphocytic Leukemia (CLL)…
Can Culturing CAR T Cells With Ibrutinib Improve Their Efficacy in CLL?
There’s a growing recognition that some of the CAR-T shortfalls in CLL are due to an impaired…
World Leukemia Day – 4 September 2020
We are looking for people from all around the globe to participate in increasing the awareness of…
CLL Advocates NZ Newsletter Issue 3
Welcome to issue 3 of the CLL Advocates newsletter. This month's newsletter focuses on research and…
“Medical Cannabis: Knowledge, Attitudes and Expectations amongst NZ Health Care Professionals and their Patients”
The aim of the study is to find out what doctors and patients in New Zealand currently know about…
CLL Diagnosis Preceded by Decades of Increased Infection Susceptibility
Chronic lymphocytic leukemia (CLL) is well known for its close relationship with immune…
Burger Reviews BTK Inhibitors and Beyond in Frontline CLL
During a virtual Case Based Peer Perspectives event, Jan A. Burger, MD, PhD, discussed testing and…
Coutre Evaluates Treatment Options in Relapsed/Refractory CLL
During a virtual Case Based Peer Perspectives event, Steven Coutre, MD, reviewed a case of a…
COVID-19 Severity in CLL Correlates With 3 Disease Characteristics
The severity of coronavirus disease 2019 increases with age in patients with chronic lymphocytic…
Online webinar: Aggressive CLL Treatment Options: Are They Right for Me?
How do people living with CLL know when they may need a more aggressive treatment? Join us on…
Understanding Chronic Lymphocytic Leukemia
CURE speaks with Dr. Susan O'Brien, on behalf of the Leukemia and Lymphoma Society.
Ibrutinib May Improve CAR T-Cell Production for Patients With Chronic Lymphocytic Leukemia
Ibrutinib during CAR T-cell culture improved the yield and function of CAR T-cell products as…
TML Helps Predict Time to Treatment in CLL and its Precursor, Study Shows
Patients with chronic lymphocytic leukemia (CLL) often face months or years of uncertainty. A new…
Ball Score Predicts Benefit From Ibrutinib in CLL
The BALL score was able to identify a subset of patients with chronic lymphocytic leukemia (CLL)…
Cohen Expands on Treatment Options in Patients With Genomic Aberrations in CLL
During a virtual Case Based Peer Perspective event, Jonathon B. Cohen, MD, MS, , discussed a case…
FDA Clears clonoSEQ to Detect MRD in Chronic Lymphocytic Leukemia
ClonoSEQ, from Adaptive Biotechnologies, can detect 1 cancer cell among a million healthy cells.
Experts Outline Best Practices in the Treatment of Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is a cancer of the blood and bone marrow that can be treated to…